The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 pilot study with dose expansion of chemotherapy in combination with CD40 agonist and Flt3 ligand in metastatic triple-negative breast cancer.
 
Sangeetha M. Reddy
No Relationships to Disclose
 
Meredith Carter
No Relationships to Disclose
 
Isaac Chan
No Relationships to Disclose
 
Melanie Hullings
Employment - TrialSpark
 
Nisha Unni
Consulting or Advisory Role - AstraZeneca; Biotheranostics; Eisai; Immunomedics; Lilly; MacroGenics; Novartis; Sanofi
 
Jessica Medina
No Relationships to Disclose
 
Shahbano Shakeel
No Relationships to Disclose
 
Susan Armstrong
No Relationships to Disclose
 
Lakeisha Cade
No Relationships to Disclose
 
Farjana J. Fattah
No Relationships to Disclose
 
Chul Ahn
Leadership - Psomagen
Stock and Other Ownership Interests - Psomagen
Consulting or Advisory Role - Advarra; Chong Kun Dang Pharmaceutical; IQVIA; LSK Global; Macrogen; PPD Global; Syneos Health
Speakers' Bureau - LSK Global
 
Yisheng V. Fang
No Relationships to Disclose
 
Nan Chen
No Relationships to Disclose
 
Heather L. McArthur
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Genomic Health; Immunomedics; Lilly; Merck; Pfizer; Puma Biotechnology; Puma Biotechnology; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); ZIOPHARM Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; DAVA Pharmaceuticals; Genentech; Immunomedics; Lilly; Lilly; Lilly; Lilly; Merck; Pfizer; Puma Biotechnology; Spectrum Pharmaceuticals
Other Relationship - Genomic Health; Lilly
 
Nicole Sinclair
Employment - Celldex
Stock and Other Ownership Interests - Celldex
 
Michael Jay Yellin
Employment - Celldex
Stock and Other Ownership Interests - Celldex
Travel, Accommodations, Expenses - Celldex
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Gilead Sciences; GRAIL; Halozyme; HERON; Immunomedics; Ipsen; Lilly; Merck; Myriad Pharmaceuticals; Nektar; Novartis; Pfizer; Pharmacyclics; Pierre Fabre; Prime Oncology; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax; Synthon; Taiho Oncology; Takeda
Consulting or Advisory Role - Abbvie; Agendia; Amgen; Aptitude Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Clovis Oncology; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Gilead Sciences; GRAIL; Halozyme; HERON; Immunomedics; Ipsen; Lilly; Merck; Myriad Pharmaceuticals; Nektar; Novartis; Pfizer; Pharmacyclics; Pierre Fabre; Prime Oncology; Puma Biotechnology; Roche; Samsung; Sanofi; Seagen; Syndax; Synthon; Taiho Oncology; Takeda
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer
Research Funding - Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie; Agendia; Amgen; AstraZeneca; Celgene; Eisai; GRAIL; Ipsen; Lilly; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Seagen
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; Cardinal Health; Cardinal Health; Fujifilm; Gilead Sciences; Immunomedics; Infinity Pharmaceuticals; ITeos Therapeutics; Merck; OBI Pharma; OncoSec; Seagen
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Seagen (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Suzanne D. Conzen
No Relationships to Disclose
 
Carlos L. Arteaga
Stock and Other Ownership Interests - Provista Diagnostics
Consulting or Advisory Role - Arvinas; AstraZeneca; Athenex; Daiichi Sankyo; Immunomedics; Lilly; Merck; Novartis; Origimed; Puma Biotechnology; Radius Health; Sanofi; Taiho Pharmaceutical
Research Funding - Lilly; Pfizer; Takeda
Other Relationship - Susan G. Komen for the Cure
(OPTIONAL) Uncompensated Relationships - Susan G. Komen for the Cure